NATCO receives DCG(I) approval for hepatitis C drug
The company plans to launch this combination drug immediately, under its brand name Hepcinat LP
Natco Pharma has received…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Home » Latest Updates » Page 342
Browsing Category
Latest Updates
World-class cancer research facility to open in Adelaide
Adelaide’s Centre for Cancer Biology received a $2 million grant from Australian Cancer Research Foundation to establish the…
Sun Pharma divests US manufacturing unit
Divests Bryan unit to Nostrum Laboratories
Sun Pharmaceutical Industries announced that as a part of its manufacturing…
Natco settles patent suit with Gilead, others
Under the terms of the settlement, Natco's partner Alvogen will be able to market the oseltamivir phosphate capsules
Natco Pharma…
Hetero bags DCG(I) approval for generic version of ‘Daclatasvir’
The product in combination with Sofosbuvir is indicated for the treatment of Hepatitis C genotype 3 infections
Hetero has…
US FDA approves first emergency treatment for overdose of certain types of chemotherapy
An overdose of fluorouracil or capecitabine is rare, but when it occurs, the effects are serious and can be fatal
The US Food and…
US-based Hysun forays into India market
Ties up with Phyto Biotech, launches diabetic supplement ‘Suga Balanz’
US-based biotechnology company, Hysun, has made its debut…
Abbott, UCSF publish research identifying new human virus
Eight complete strains of HpgV-2 were identified
Abbott and University of California San Francisco (UCSF) published research…
TCS partners with Vanderbilt University Medical Center
Drive innovation in the healthcare and life sciences fields
Tata Consultancy Services announced a new partnership with Vanderbilt…
Dengue vaccine Dengvaxia approved in Mexico
First marketing authorization of Dengvaxia is a historic milestone paving the way to significantly impact dengue burden in endemic…